Contribution of the KSHV and EBV lytic cycles to tumourigenesis (Q59351570)

1 July 2019

6 references

3 November 2019

15 September 2020

18 September 2020

5 November 2020

1 December 2020

24 January 2021

Contribution of the KSHV and EBV lytic cycles to tumourigenesis (English)

1 reference

1 July 2019

1 reference

3 November 2019

viral genome replication

2 references

15 September 2020

5 November 2020

1 reference

1 December 2020

1 reference

24 January 2021

Oliver Manners

1

0 references

James C Murphy

object named as

James C Murphy

2

0 references

Adrian Whitehouse

object named as

Adrian Whitehouse

5

0 references

author name string

Alex Coleman

3

1 reference

1 July 2019

David J Hughes

4

1 reference

1 July 2019

language of work or name

English

0 references

publication date

28 September 2018

1 reference

1 July 2019

full work available at URL

1 October 2018

6 references

3 November 2019

15 September 2020

18 September 2020

5 November 2020

1 December 2020

24 January 2021

http://eprints.whiterose.ac.uk/135700

content deliverer

White Rose Research Online

object of statement has role

published version

copyright license

Creative Commons Attribution 4.0 International

0 references

https://doi.org/10.1016/j.coviro.2018.08.014

object of statement has role

published version

copyright license

Creative Commons Attribution 4.0 International

0 references

published in

Current opinion in virology

2 references

1 July 2019

24 January 2021

32

1 reference

1 July 2019

page(s)

60-70

1 reference

1 July 2019

Creative Commons Attribution 4.0 International

copyright license

5 references

3 November 2019

15 September 2020

5 November 2020

1 December 2020

Persistence of Epstein-Barr virus in Reed-Sternberg cells throughout the course of Hodgkin's disease.

24 January 2021

cites work

1 reference

12 December 2020

Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1

1 reference

12 December 2020

Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA

1 reference

12 December 2020

trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment

1 reference

12 December 2020

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

12 December 2020

Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

1 reference

12 December 2020

Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space

1 reference

12 December 2020

Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines

1 reference

12 December 2020

The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

12 December 2020

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

12 December 2020

Expression of the DNase encoded by the BGLF5 gene of Epstein-Barr virus in nasopharyngeal carcinoma epithelial cells.

1 reference

12 December 2020

Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma

1 reference

12 December 2020

A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit

1 reference

12 December 2020

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

1 reference

12 December 2020

The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

1 reference

12 December 2020

Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus

1 reference

12 December 2020

Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74

1 reference

12 December 2020

Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus

1 reference

12 December 2020

Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

1 reference

12 December 2020

Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.

1 reference

12 December 2020

Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus and sexual transmission of cancer risk

1 reference

12 December 2020

KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways

1 reference

12 December 2020

Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells

1 reference

12 December 2020

The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators

1 reference

12 December 2020

The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha

1 reference

12 December 2020

The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B.

1 reference

12 December 2020

HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators

1 reference

12 December 2020

Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus

1 reference

12 December 2020

Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.

1 reference

12 December 2020

Inhibition of p53 tumor suppressor by viral interferon regulatory factor

1 reference

12 December 2020

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder

1 reference

12 December 2020

Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects

1 reference

12 December 2020

The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element

1 reference

12 December 2020

HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation

1 reference

12 December 2020

Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus

1 reference

12 December 2020

Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

1 reference

12 December 2020

Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein

1 reference

12 December 2020

Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.

1 reference

12 December 2020

The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase

1 reference

12 December 2020

Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies

1 reference

12 December 2020

Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy

1 reference

12 December 2020

Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model

1 reference

12 December 2020

Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis

1 reference

12 December 2020

An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus

1 reference

12 December 2020

Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.

1 reference

12 December 2020

Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers

1 reference

12 December 2020

Larger than life: Mitochondria and the Bcl-2 family

1 reference

12 December 2020

Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus

1 reference

12 December 2020

Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion

1 reference

12 December 2020

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

1 reference

12 December 2020

The Galpha12/13 family of heterotrimeric G proteins and the small GTPase RhoA link the Kaposi sarcoma-associated herpes virus G protein-coupled receptor to heme oxygenase-1 expression and tumorigenesis

1 reference

12 December 2020

X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency

1 reference

12 December 2020

Kaposi's sarcoma revisited.

1 reference

12 December 2020

EBV-associated lymphoproliferative disorders: classification and treatment

1 reference

12 December 2020

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link

1 reference

12 December 2020

EBV and genomic instability--a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma.

1 reference

12 December 2020

Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression

1 reference

12 December 2020

Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis

1 reference

12 December 2020

Induction of angiogenic chemokine CCL2 by human herpesvirus 8 chemokine receptor

1 reference

12 December 2020

Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells

1 reference

12 December 2020

Human gamma-herpesviruses: a review of 2 divergent paths to oncogenesis

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs

1 reference

12 December 2020

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

1 reference

12 December 2020

Immune Evasion by Kaposi‘s Sarcoma-Associated Herpesvirus

1 reference

12 December 2020

Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis

1 reference

12 December 2020

The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways

1 reference

12 December 2020

EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.

1 reference

12 December 2020

Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug

1 reference

12 December 2020

Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma

1 reference

12 December 2020

An interaction between KSHV ORF57 and UIF provides mRNA-adaptor redundancy in herpesvirus intronless mRNA export.

1 reference

12 December 2020

Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.

1 reference

12 December 2020

Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression

1 reference

12 December 2020

A role for Epstein-Barr viral BALF1 in facilitating tumor formation and metastasis potential.

1 reference

12 December 2020

EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes

1 reference

12 December 2020

Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir.

1 reference

12 December 2020

The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes?

1 reference

12 December 2020

Epstein-Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality

1 reference

12 December 2020

Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression

1 reference

12 December 2020

Lytic infection of Kaposi's sarcoma-associated herpesvirus induces DNA double-strand breaks and impairs non-homologous end joining.

1 reference

12 December 2020

Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells

1 reference

12 December 2020

First IL-6-blocking drug nears approval for rare blood disorder

1 reference

12 December 2020

Rituximab in the treatment of EBV-positive low grade B-cell lymphoma

1 reference

12 December 2020

Regulation of the latent-lytic switch in Epstein-Barr virus

1 reference

12 December 2020

A gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivo

1 reference

12 December 2020

A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells

1 reference

12 December 2020

Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule

1 reference

12 December 2020

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma

1 reference

12 December 2020

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease

1 reference

12 December 2020

KSHV targeted therapy: an update on inhibitors of viral lytic replication

1 reference

12 December 2020

The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development

1 reference

12 December 2020

Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation

1 reference

12 December 2020

Identification of the Essential Role of Viral Bcl-2 for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.

1 reference

12 December 2020

NEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV target

1 reference

12 December 2020

K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.

1 reference

12 December 2020

Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK.

1 reference

12 December 2020

Activation of DNA Damage Response Pathways during Lytic Replication of KSHV.

1 reference

12 December 2020

MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling

1 reference

12 December 2020

Hsp70 Isoforms Are Essential for the Formation of Kaposi's Sarcoma-Associated Herpesvirus Replication and Transcription Compartments

1 reference

12 December 2020

Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding

1 reference

12 December 2020

The Role of Gammaherpesviruses in Cancer Pathogenesis

1 reference

12 December 2020

The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication

1 reference

12 December 2020

Targeting the ATP-dependent formation of herpesvirus ribonucleoprotein particle assembly as an antiviral approach

1 reference

12 December 2020

Epstein-Barr virus particles induce centrosome amplification and chromosomal instability

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally.

1 reference

12 December 2020

Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.

1 reference

12 December 2020

EBV and Apoptosis: The Viral Master Regulator of Cell Fate?

1 reference

12 December 2020

Vaccine Development for Epstein-Barr Virus

1 reference

12 December 2020

10.1016/J.COVIRO.2018.08.014

Identifiers

DOI

1 reference

1 July 2019

10.1016/J.COVIRO.2018.08.014

Altmetric DOI

0 references

CORE ID

161931954

0 references

Dimensions Publication ID

1107273954

0 references

Microsoft Academic ID

0 references

1 reference

1 July 2019

PubMed publication ID

30268927

1 reference

1 July 2019